According to the Centres for Disease Control and Prevention (CDC), approximately 105,000 people died from drug overdoses in 2023, with nearly 80,000 of those deaths linked to opioids. This alarming rise in opioid overdoses and related fatalities highlights the urgent need for effective interventions.
Medication-assisted treatment for opioid addiction offers a proven path to recovery. Read on to learn how it works and why it has become one of the most sought-after treatment options.
What is Medication-Assisted Treatment for Opioid Addiction?
Opioid addiction, clinically known as Opioid Use Disorder (OUD), is a chronic disease that affects both the mind and body. It can range from mild to severe and often involves tolerance (needing higher doses to achieve the same effect), withdrawal symptoms, and cravings that are difficult to control.
Medication-assisted treatment (MAT) combines pharmacotherapy with counselling and behavioural therapy to address both the biological and psychological components of opioid addiction. The goal is not only to achieve physical stabilisation but also to create space for mental health healing.
MAT for OUD helps by balancing brain chemistry, reducing cravings, and easing opioid withdrawal symptoms, much like how medications are used to manage other chronic health conditions.

FDA-Approved Medications for Opioid Use Disorder
Pharmacological treatment for OUD relies on different medications to maintain abstinence. The Food and Drug Administration approved three drugs that have been clinically proven to support recovery. Here are the primary prescription opioids used in treatment programs:
Methadone
Methadone is a long-acting full opioid agonist that helps reduce cravings and withdrawal symptoms without producing the intense high associated with drugs like heroin or oxycodone.
Due to its potential for misuse, methadone is typically administered in a regulated clinic setting under close medical supervision. OUD treatment often involves a daily methadone dose or regularly scheduled doses, sometimes extending a year or more, depending on individual needs.
Buprenorphine
Buprenorphine is a partial opioid agonist, meaning it activates opioid receptors in the brain but with less intensity than full opioids. This helps control urges and withdrawal symptoms without producing a strong euphoric effect, making it safer and lowering the risk for overdose.
Doses of buprenorphine are available in formulations like Subutex and Suboxone (with naloxone). Unlike methadone, it can be prescribed for at-home use and has a “ceiling effect,” which limits its impact at higher dosages.
Naltrexone
Naltrexone is an opioid antagonist that completely blocks opioid receptors, preventing any high from opioid use. It comes in two forms: a daily oral tablet (Revia) and a monthly injection (Vivitrol).
While non-addictive and non-sedating, Naltrexone requires the individual to be fully detoxed before starting the medication, as taking it too soon after drug use can trigger intense withdrawal. Although it doesn’t ease urges, it acts as a strong deterrent by making opioid use feel ineffective.

How Do Psychotherapies Strengthen MAT Treatment?
Integrating psychotherapy with medication-assisted treatment for opioid addiction creates a well-rounded approach to lasting recovery. Below are key evidence-based therapies that address different aspects of substance abuse and mental health:
Cognitive Behavioural Therapy (CBT) to Modify Patterns and Build Coping Skills
Cognitive behavioural therapy is one of the most widely used and effective therapeutic approaches in the treatment of OUD. It helps patients identify and modify harmful thought patterns and behaviours that reinforce substance use, while also building healthier coping mechanisms for stress and triggers.
A 2024 study found that patients receiving medication for OUD responded positively to CBT. It not only enhanced engagement but also contributed to a complete cessation of opioid use.
Using Contingency Management (CM) to Strengthen Attendance and Abstinence
CM uses rewards to reinforce favourable behaviour. When patients achieve specific treatment goals, such as passing urine drug screens or consistently attending treatment, they earn incentives.
These rewards can include vouchers, gift cards, or privileges, offering additional motivation to stay engaged in the recovery process. Therapists set clear expectations and closely monitor progress, helping to maintain accountability and support long-term change.

Family Therapy to Rebuild Trust
Family therapy helps rebuild trust, enhance communication, and support long-term sobriety. Involving loved ones in the treatment process strengthens the support system and addresses family dynamics that may have contributed to substance abuse.
Sessions focus on setting healthy boundaries, developing effective problem-solving skills, and fostering empathy and understanding within the family unit without enabling problem behaviour.
Group Therapy to Sustain Recovery
Group therapy creates a safe and supportive environment where people with shared experiences and struggles can connect and learn from one another. Sessions typically focus on building coping strategies, sharing personal insights, and fostering a sense of community.
This collective support helps reduce isolation, promotes mutual encouragement, and strengthens accountability, all of which enhance commitment and support relapse prevention.
Motivational Interviewing (MI) to Improve Engagement to Change
Motivational interviewing is a client-centred counselling approach that guides individuals toward positive change without pressure or judgment. Instead of giving direct advice or instructions, the therapist uses open-ended questions to help explore internal motivation to heal.
Through empathy and reflective listening, MI helps explore personal values, goals, and the impact of opioid misuse, ultimately empowering meaningful, self-directed change.
Starting Treatment for Opioid Use Disorder
Selecting the best substance abuse treatment setting depends on several factors, such as the severity of dependence, personal lifestyle, and the level of support needed. Each setting offers different levels of structure and primary care to help support recovery.

Who Benefits Most From Inpatient Treatment?
Inpatient or residential treatment requires patients to stay full-time at a facility where they receive comprehensive medical care and therapeutic support. This option is recommended for those with severe dependence, a history of relapse or complications, or an unstable living environment.
Residential programs usually start with medical detoxification, followed by a structured program of psychotherapy, group counselling, psychoeducation, and recovery workshops.
When Is A Flexible Outpatient Plan Appropriate?
Outpatient programs allow people to live at home while attending scheduled treatment sessions, typically once or twice a week. This flexible approach is suitable for those with less severe symptoms, strong support networks, or those transitioning from inpatient care.
Options often include standard outpatient programs, intensive outpatient programs (IOPs), and partial hospitalisation programs (PHPs), all offering adequate support without requiring overnight stays.
Get Help for Opioid Dependence
Opioid addiction can quietly take hold, but it doesn’t have to take over your life. If you or someone you care about is struggling, now is the best time to seek help.
At Kembali, we offer evidence-based treatment for a range of substance use disorders to support you on the path to healing. Take the first step today, our expert staff and team are here for you.
Frequently Asked Questions
What are the approved medications used in the treatment of opioid addiction?
The FDA-approved medications include methadone, buprenorphine, and naltrexone. These medications are prescribed based on individual needs.
How does medication-assisted treatment (MAT) work to treat opioid dependence?
MAT services work by using medications to act on the same brain receptors as opioids, but in a controlled way. This helps ease cravings and withdrawal symptoms without causing a high.
What are the potential side effects of medications used in opioid addiction treatment?
Patients on methadone and buprenorphine may experience drowsiness, constipation, or sweating, while naltrexone can lead to nausea, fatigue, or headache. The effects are generally manageable under medical supervision.
Can medication-assisted treatment be used in conjunction with counselling and behavioural therapies?
MAT is most effective when combined with counselling and psychotherapy, as it addresses the physical, psychological, and emotional aspects of opioid dependence.
What is the process for starting medication-assisted treatment for opioid addiction?
Entering treatment often begins with a comprehensive assessment, which may include medical history, substance use, and other medications. Based on this, a treatment plan will be tailored and adjusted.
How long does a patient typically remain on medication-assisted treatment for opioid addiction?
The duration of a MAT program for OUD treatment mainly depends on individual needs, progress, and effectiveness. MAT may be used for months, and for some, even years.



